The trials listed below are accepting new patients.  Interested patients can Email the coordinator by clicking on envelope icon. Please include a phone number and best times to call.

Treatment stage
Short Name
Protocol Title 
ClinicalTrials.Gov Link
Penn Research Coordinator 
Am I Eligible?
Recurrent MYTHIC

Phase 1 Study of the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of RP-6306 in Patients with Advanced Solid Tumors

NCT4855656 Andrea Standish, RN Eligibility Criteria 
Recurrent MAGNETIC Phase 1 Study of the PKMYT1 Inhibitor RP-6306 in Combination with Gemcitabine for the Treatment of Advanced Solid Tumors  NCT05147272 Andrea Standish, RN Eligibility Criteria
Recurrent FAETH A Phase 1b Study of Serabelisib in Combination with an Insulin Suppressing Diet (Study ISD) in Subjects with Advanced Solid Tumors with PIK3CA Mutations with or without PTEN loss NCT05300048 Katie Elkins

Eligibility Criteria 

Enrollment on Hold

Recurrent ATRIN A Phase 1/2a, Open-Label, Safety, Pharmacokinetic, and Preliminary Efficacy Study of Oral ATRN-119 in Patients with Advanced Solid Tumors NCT04905914 Andrea Standish, RN  Eligibility Criteria
Recurrent Xencor A Phase 2 Study of XmAb®20717 in Patients With Selected Gynecological Malignancies and High-Risk Metastatic Castration-Resistant Prostate Cancer NCT05032040 Isabel Forbes Eligibility Criteria
Recurrent NP-G2-044-P2-01 NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies NCT05023486 Shavon Rochester Eligibility Criteria
Primary Radiation


Whole Pelvis Proton Radiation for Gynecologic Cancer

NCT05758688 Kelly Clark Eligibility Criteria
Surgery GOG 3043 A Randomized Controlled Trial of Robotic versus Open Radical Hysterectomy for Cervical Cancer
(ROCC trial)
NCT04831580 Destany Fields Eligibility Criteria